Drug · DIN 02237713 · Veterinary
ORBAX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 12, 2024; first marketed May 13, 1998.
- Drug Identification Number (DIN)
- 02237713
- Company (DIN owner)
- Intervet Canada CorpKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ORBIFLOXACIN | 22.7 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 16, 2009: NOC 10673New Drug Submission (NDS) · Change in Ownership
- April 6, 1998: NOC 6875New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “orbax”. A notice may cover another product or only some lots: read it to see what it covers.
- ORBAX: Labelling IssueApril 6, 2022 · Veterinary drugs · Labelling · Type III
Other DINs named ORBAX
- DIN 02237712 · Cancelled Post Market
- DIN 02237714 · Cancelled Post Market